Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19.
Makoto KuranoKoh OkamotoDaisuke JubishiHideki HashimotoEri SakaiDaisuke SaigusaKuniyuki KanoJunken AokiSohei HaradaShu OkugawaKent DoiKyoji MoriyaYutaka YatomiPublished in: Clinical and translational medicine (2022)
A better understanding of the disturbances in sphingolipids and glycerophospholipids observed in this study will prompt further investigation to develop laboratory testing for predicting maximum severity and/or novel agents to suppress the aggravation of COVID-19.